SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$3.72B
This Quarter Return
+0.92%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$5.97B
AUM Growth
+$8.01M
(+0.13%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
7.91%
Holding
1,265
New
201
Increased
308
Reduced
441
Closed
210
Top Buys
| 1 |
General Dynamics
GD
|
+$46.3M |
| 2 |
Cigna
CI
|
+$45.9M |
| 3 |
Amgen
AMGN
|
+$43.3M |
| 4 |
Honeywell
HON
|
+$40.7M |
| 5 |
American Water Works
AWK
|
+$32.1M |
Top Sells
| 1 |
Philip Morris
PM
|
+$53.8M |
| 2 |
Bank of New York Mellon
BK
|
+$37.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$36.3M |
| 4 |
Pfizer
PFE
|
+$34.5M |
| 5 |
Schlumberger
SLB
|
+$32.6M |
Sector Composition
| 1 | Technology | 14.22% |
| 2 | Financials | 14.16% |
| 3 | Industrials | 14.02% |
| 4 | Healthcare | 13.7% |
| 5 | Consumer Discretionary | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Omeros
OMER
$282M
| $113K | ﹤0.01% |
13,764
-136,793
| -91% | -$1.12M |
|
|
CKPT
1027
DELISTED
Checkpoint Therapeutics
CKPT
| $106K | ﹤0.01% |
+26,334
| New | +$106K |
|
1028
RE/MAX Holdings
RMAX
$197M
| $101K | ﹤0.01% |
12,094
-7,867
| -39% | -$65.8K |
|
1029
Xeris Biopharma Holdings
XERS
$1.21B
| $93.8K | ﹤0.01% |
17,087
-2,625
| -13% | -$14.4K |
|
1030
Fate Therapeutics
FATE
$112M
| $93.4K | ﹤0.01% |
118,186
| – | – |
|
1031
Annexon
ANNX
$268M
| $79.2K | ﹤0.01% |
41,011
-78,714
| -66% | -$152K |
|
1032
Phathom Pharmaceuticals
PHAT
$832M
| $71.9K | ﹤0.01% |
+11,473
| New | +$71.9K |
|
1033
Fastly
FSLY
$1.12B
| $69K | ﹤0.01% |
10,900
-248,394
| -96% | -$1.57M |
|
1034
Rayonier Advanced Materials
RYAM
$419M
| $67K | ﹤0.01% |
11,651
-22,732
| -66% | -$131K |
|
|
DADA
1035
DELISTED
Dada Nexus
DADA
| $66.1K | ﹤0.01% |
35,705
-16,690
| -32% | -$30.9K |
|
1036
Erasca
ERAS
$443M
| $64.1K | ﹤0.01% |
46,785
-45,996
| -50% | -$63K |
|
1037
ARKO Corp
ARKO
$568M
| $60.9K | ﹤0.01% |
15,408
-62,892
| -80% | -$248K |
|
1038
Astria Therapeutics
ATXS
$428M
| $59K | ﹤0.01% |
+11,051
| New | +$59K |
|
1039
Vivid Seats
SEAT
$112M
| $54.5K | ﹤0.01% |
+921
| New | +$54.5K |
|
1040
Babcock & Wilcox
BW
$279M
| $45.4K | ﹤0.01% |
67,566
-81,422
| -55% | -$54.7K |
|
1041
Aclaris Therapeutics
ACRS
$211M
| $44.9K | ﹤0.01% |
+29,316
| New | +$44.9K |
|
1042
Ribbon Communications
RBBN
$682M
| $43.5K | ﹤0.01% |
11,100
-10,238
| -48% | -$40.1K |
|
1043
Valens Semiconductor
VLN
$193M
| $42K | ﹤0.01% |
+20,607
| New | +$42K |
|
1044
ProKidney
PROK
$337M
| $39.2K | ﹤0.01% |
44,707
-7,421
| -14% | -$6.5K |
|
|
OPI
1045
Office Properties Income Trust
OPI
$40M
| $36.3K | ﹤0.01% |
79,675
-76,019
| -49% | -$34.7K |
|
|
HTZWW
1046
Hertz Global Holdings Warrants
HTZWW
$300M
| $29.6K | ﹤0.01% |
13,092
| – | – |
|
1047
Accuray
ARAY
$183M
| $29K | ﹤0.01% |
16,190
-17,164
| -51% | -$30.7K |
|
|
DDL
1048
Dingdong
DDL
$475M
| $28.9K | ﹤0.01% |
10,694
| – | – |
|
1049
Cardlytics
CDLX
$58M
| $26.6K | ﹤0.01% |
14,628
-74,579
| -84% | -$136K |
|
1050
Sutro Biopharma
STRO
$75.1M
| $24.7K | ﹤0.01% |
37,956
-49,854
| -57% | -$32.4K |
|